FDA Inspection 1286070 — Dompe Farmaceutici S.P.A.
The FDA completed an inspection of Dompe Farmaceutici S.P.A. on Sep 20, 2022 in L'Aquila. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 20, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- L'Aquila (Italy)
Additional details
Mutual Recognition Agreement (MRA)